Literature DB >> 35528386

Relationship between Mucosal Barrier Function of the Oviduct and Intestine in the Productivity of Laying Hens.

Takahiro Nii1,2.   

Abstract

The mucosa of the intestine and oviduct of hens are susceptible to pathogens. Pathogenic infections in the mucosal tissues of laying hens lead to worsened health of the host animal, decreased egg production, and bacterial contamination of eggs. Therefore, better understanding of the mechanisms underlying mucosal barrier function is needed to prevent infection by pathogens. In addition, pathogen infection in the mucosal tissue generally causes mucosal inflammation. Recently, it has been shown that inflammation in the oviduct and intestinal tissue caused by disruption of the mucosal barrier function, can affect egg production. Therefore, it is vitla to understand the relationship between mucosal barrier function and egg production to improve poultry egg production. This paper reviews the studies on (1) oviductal mucosal immune function and egg production, (2) intestinal inflammation and egg production, and (3) improvement of mucosal immune function by probiotics. The findings introduced in this review will contribute to the understanding of the mucosal barrier function of the intestine and oviduct and improve poultry egg production in laying hens. 2022, Japan Poultry Science Association.

Entities:  

Keywords:  egg production; inflammation; intestine; mucosal barrier; oviduct

Year:  2022        PMID: 35528386      PMCID: PMC9039148          DOI: 10.2141/jpsa.0210090

Source DB:  PubMed          Journal:  J Poult Sci        ISSN: 1346-7395            Impact factor:   1.768


1. Introduction

Pathogenic infections of the intestinal tract and oviduct negatively impact the health of host animals and contaminated eggs cause food poisoning in humans. Ameliorating infectious disease prevention is vital to maintain chicken health and to produce safe eggs. Chickens have a mucosal barrier in their digestive and reproductive tracts, because the mucosal tissue, as an “outside of the inside” tissue, is exposed to external bacteria and viruses. The mucosal barrier consists of four parts: the biological barrier formed by microbiota, chemical barrier formed by mucus including antimicrobial peptides and antibodies, mechanical barrier formed by tight junctions between mucosal epithelial cells, and immune barrier consisting of immune-competent cells in the lamina propria (Wang ). These barriers work together to prevent pathogenic infections in mucosal tissues. An understanding of the control mechanisms and enhancement of mucosal barrier function should help prevent infection in chickens. With the expansion of bans on growth-promoting antibiotics in poultry feed, new problems, such as disruption of the intestinal environment due to intestinal infection (Huyghebaert ; Ducatelle ). Non-caged house systems, such as deep litter, free range, and organic systems, are major breeding systems that improve poultry welfare in terms of behavioral freedom in the EU (Sokołowicz ). However, non-caged house systems also bring another problem in the form of an increased risk of pathogenic infections such as coccidiosis, rubella, E. coli, pasteurellosis, histomoniasis, and ascariasis in comparison to cage systems (Relic ; Bari ). Therefore, protecting chickens from these pathogens by ameliorating the mucosal barrier function of the intestine and oviduct is becoming increasingly important. In addition, it has been suggested that the oviductal mucosal immune reaction caused by antigen stimulation affects egg production. Intestinal inflammation caused by disruption of mucosal barrier function may also strongly affect egg production in laying hens. Understanding the mechanism of the relationship between mucosal barrier function and egg production is important for the improvement of egg production. This review introduces (1) the regulation of oviductal mucosal immune function and egg production, (2) the effects of intestinal inflammation on egg production, and (3) enhancement of intestinal mucosal barrier function by probiotic treatment.

2. Oviductal mucosal immune function and egg production

2-1. Regulation of Mucosal Immune Function in the Oviduct

The hen oviduct is susceptible to infections by bacterial and viral pathogenic microorganisms. When these organisms (such as Salmonella, Escherichia coli, and Mycoplasma) infect the oviduct, it leads to functional disorders of egg formation and concomitant production of contaminated eggs (Feberwee ; Gantois ; Neubauer ; Ozaki and Murase, 2009). Contamination of eggs increases the mortality of newly hatched chicks and causes foodborne diseases in humans. For example, Salmonella Enteritidis is phagocytized by intestinal macrophages, which may then translocate to the ovary and oviduct through the bloodstream (De Buck ). These pathogens colonizing the cloaca may invade the oviduct through the vagina. Therefore, enhancing the mucosal barrier function of the hen oviduct is needed to prevent pathogenic infections and maintain hygienic egg production. Oviduct tissue has unique characteristics; namely, the development and regression of the oviduct tissue are regulated by gonadal steroids. Zheng reported that estrogen stimulates the growth and differentiation of oviductal mucosal cells, as well as the influx of immunocompetent cells such as T and B cells. The report suggests that the mucosal immune function of the oviduct may be affected by gonadal steroids, similar to oviductal tissue. Similarly, the oviduct is more susceptible to bacterial infection in the molting phase, which is the non-laying phase with lower gonadal steroid concentration, compared with normal laying conditions (Holt, 1993; Gantois ). In addition, eggs laid by post-molting hens were more heavily contaminated than those of pre-molting hens (Golden ). Lipopolysaccharides (LPS) are components of the gram-negative bacterial cell wall, and it is recognized by toll-like receptor (TLR) 4, which triggers an immune response. The recruitment of CD8+ T cells by LPS stimulation in the hen oviduct was decreased during the molting phase, and this may be a reason why the susceptibility to infections is higher during the molting phase (Nii ). We also reported that the cellular immune response to the infectious bronchitis (IB) viral antigen stimulation was decreased with lower TLR7 gene expression during the molting phase in the oviductal mucosa, but the responsiveness was recovered by estrogen stimulation (Nii ). Similarly, mRNA expression levels of Claudin-1, -3, -5 and protein expression of Claudin-1 were significantly decreased in molting hens, but these expressions were recovered by estrogen stimulation in the oviduct of laying hens (Ariyadi ). The gene and protein expression of avian β-defensin (AvBD)-11, a component of the chemical barrier, was enhanced by estrogen stimulation in the hen oviduct (Lim, ). In addition, AvBD expression was decreased in the mucosal epithelium of the regressed oviduct of molting hens (Yoshimura ). Therefore, estrogen plays an important role in enhancing the chemical, physical, and immunological barriers in the oviductal mucosa of laying hens. The frequency of antigen exposure is factor that affects the mucosal immune function of the oviduct. The density of T cells was higher in the vagina than in the other parts of the laying hen oviduct (Withanage ; Yoshimura ). The vagina opens to the cloaca, and this segment is exposed to antigens colonizing the cloaca. Therefore, it is expected that exposure to proper antigens may enhance the immune function of the oviduct. In fact, LPS stimulation conducted five times increased the numbers of CD4+, CD8+, and TCRγδ+ T cells in the mucosal tissue of the vagina of laying hens, but they did not change after a single LPS stimulation (Nii ). This suggests that proper antigen stimulation may be effective for the accumulation of the T cell pool in the oviductal mucosa, and these cells may contribute to protection from antigen infection. Thus, proper antigen stimulation results in a T cell subset pool, which may contribute to the prequiescence of host immunity in the oviductal mucosa, and estrogen stimulation may be responsible for enhancing oviductal mucosal barrier function. To increase the production of high-quality eggs by enhancing the mucosal barrier function in the oviduct, the establishment of the following methods in the oviduct may be considered: (1) stimulation with the effective antigen and (2) reinforcement of estrogen efficacy by increasing estrogen levels or receptor expression.

2-2. Immune Function of the Oviductal Mucosa and Egg Pro duction

The IB virus infects bronchial tubes and causes respiratory disease in chickens. This virus also infects the epithelial surface of the oviduct through blood circulation from bronchitis to the kidney and translocation from the kidney to the cloaca, reaching the oviduct (Dolz ). Infection by the IB virus leads to disordered eggshell formation and a decline in egg production (Feberwee and Landman, 2010). Thus, how IB virus infection causes egg production disorders is an important question. It has been reported that IB virus infection negatively affects eggshell formation by disturbing the gene expression of collagen type I in the isthmus and CaBP-D28K (calbindin) is associated with increased proinflammatory cytokine gene expression in the uterus (Nii ). In addition, both IL-1β and IL-6 stimulation significantly decreased CaBP-D28K protein density in cultured uterine tissue compared to that in the control group (Nii ). These reports suggest that proinflammatory cytokines produced by viral infection lead to eggshell malformation through a decrease in CaBP-D28K protein expression. H9N2 avian influenza virus infection increased proin flammatory cytokine expression in the uterus as well as disturbed eggshell formation through a decrease in CaBP-D28K (Wang ; Qi ). This report supports the investigation of the mechanism of eggshell malformation caused by viral infection. Therefore, bacterial or viral infection in the oviduct may cause disorder of eggshell formation through an increase in proinflammatory cytokines and a decrease in CaBP-D28K protein density. Preventing pathogenic infections, namely pathological mucosal inflammation, in the hen oviduct is important for healthy egg production in laying hens. Collectively, cytokine production and attraction of lymphocytes through the interaction with TLRs with their ligands are important to prevent infections by pathogenic bacteria and viruses in the hen oviduct (Fig. 1). Estrogen is likely necessary for enhancing the immune reaction in the oviduct. Recent studies have also established that eggshell malformation caused by pathological microbe infection is likely led by the production of IL-1β and IL-6 induced by microbial infection. This knowledge is expected to be useful for the development of technology for preventive hygiene in the oviduct and production of eggs.
Fig. 1.

Representative diagram describing the regulatory mechanism of the recruitment of cytotoxic cells in hen oviduct, and eggshell malformation caused by infection. Cytokines are released and cytotoxic cells are recruited through the interaction between Tool-like receptors and its ligands by pathogenic bacteria and virus infection in hen oviductal mucosa. These immunoresponse is weakened during molting phase, but estrogen is likely to enhance this response. IL-1β and IL-6 produced by pathological microbe infection lead eggshell malformation through the degradation of calbindin protein. It is likely the cytotoxic cells and cytotoxic factors led by infection also affects eggshell malformation.

Representative diagram describing the regulatory mechanism of the recruitment of cytotoxic cells in hen oviduct, and eggshell malformation caused by infection. Cytokines are released and cytotoxic cells are recruited through the interaction between Tool-like receptors and its ligands by pathogenic bacteria and virus infection in hen oviductal mucosa. These immunoresponse is weakened during molting phase, but estrogen is likely to enhance this response. IL-1β and IL-6 produced by pathological microbe infection lead eggshell malformation through the degradation of calbindin protein. It is likely the cytotoxic cells and cytotoxic factors led by infection also affects eggshell malformation.

3. Intestinal inflammation and egg production

3-1. DSS-induced Acute Heavy Intestinal Inflammation and Egg Production in Laying Hens

The chicken gut mucosa is susceptible to pathogen infection in feed or water. Pathogens such as bacteria, parasites, and viral infection of intestinal tissue lead to decreased growth performance and egg production in chickens. In particular, Eimeria, one of the principal intestinal infectious pathogens causing coccidiosis, leads to a decrease in feed intake, growth, and egg production of layer and broiler breeder hens (Lensing ; Ritzi ). This pathogenic infection increases proinflammatory cytokine production (IL-1β and IL-6) and the frequency of histological inflammatory events in the intestinal mucosa (Hong ; Belote ; Fasina and Lillehoj, 2019). These reports suggest that intestinal inflammation reduces egg production in laying hens. Dextran sulfate sodium (DSS), an inducer of intestinal inflammation, is commonly used as a model animal for colitis, inflammatory bowel disease, and colitis-associated cancer (Saleh and Trinchieri, 2011; Heijmans ). DSS directly damages epithelial cells in the intestinal mucosa, and the intestinal microbiome enters the lamina propria and causes inflammation by immunocompetent cells (Saleh and Trinchieri, 2011). The effects of DSS administration on the intestinal mucosa of chickens was verified by Menconi , who showed that 0.75% DSS in drinking water for 8 d caused depression, anemia, watery and bloody diarrhea, decreased body weight (BW), and decreased villus and epithelial cell height of the duodenum and ileum in young broiler chicks. Kuttappan examined the optimal DSS administration method for chicks. They administered two doses of oral gavage of 0.45 g DSS/bird to cause gut leakage in 3- and 4-day-old broiler chicks, because the method showed less mortality and more consistent results compared with the method using 1.25% DSS in drinking water. It was reported that DSS treatment in broiler and layer chicks caused histological damage of the intestine, including shortening and loss of villi and crypts, as well as intestinal inflammation (Simon ). These reports confirm that DSS administration in broiler and layer chicks causes several symptoms such as intestinal inflammation, similar to those of rodents. Recently, the effects of intestinal inflammation caused by DSS treatment on egg production in laying hens have also been reported (Nii ). The report showed that oral administration of DSS (0.9 g/kg BW DSS for 5 d) caused severe acute intestinal inflammation, including histological disintegration of the cecal mucosa in laying hens (Fig. 2b), which may reduce egg production by disrupting egg-yolk precursor production in association with liver inflammation caused by the influx of LPS from the intestine.
Fig. 2.

Micrographs showing the histology of the cecum in hens orally administered 0.9 g/kg BW of dextran sulphate sodium for 5 days (High-DSS group), 0.225 g/kg BW of DSS for 28 days (Low-DSS group) or water (control group). The cecum of hens in the control (A), High-DSS (B) and Low-DSS (C) groups. HE staining. Leukocytes are distributed in the lamina propria in the cecum of hens in the DSS group (arrows). The luminal epithelial cells of the cecum in the DSS group had disintegrated or were lost (arrow head). E=mucosal epithelium, L=lumen, LP= lamina propria. Scale bars=50 µm. (Nii , b).

Micrographs showing the histology of the cecum in hens orally administered 0.9 g/kg BW of dextran sulphate sodium for 5 days (High-DSS group), 0.225 g/kg BW of DSS for 28 days (Low-DSS group) or water (control group). The cecum of hens in the control (A), High-DSS (B) and Low-DSS (C) groups. HE staining. Leukocytes are distributed in the lamina propria in the cecum of hens in the DSS group (arrows). The luminal epithelial cells of the cecum in the DSS group had disintegrated or were lost (arrow head). E=mucosal epithelium, L=lumen, LP= lamina propria. Scale bars=50 µm. (Nii , b).

3-2. Slight Intestinal Inflammation and Egg Production in Laying Hens

Minor disruption of the intestinal environment without severe symptoms is related to intestinal barrier dysfunction, intestinal inflammation, and dysbiosis during the rearing period and it has become a common problem since the ban on growth-promoting antibiotics in poultry feed (Huyghebaert ; Ducatelle ). Therefore, an experimental model for long, minor disruptions of the intestinal environment are highly important to simulate real farm conditions. Oral administration of 0.225 g/kg BW DSS for 28 d led to a slight disruption of the intestinal environment; namely, shorter villi and a decrease in cecal microbiome diversity without any histological damage or symptoms (Fig. 2c) (Nii ). Slight disruption of the intestinal environment decreased egg-laying ratio and egg yolk size (Fig. 3), and this low egg productivity was likely caused by dysfunction in the egg-yolk precursor uptake in the ovarian follicle in association with an increase in circulating LPS without disrupting liver function. However, the mechanism by which egg yolk size is decreased by disruption of the intestinal environment is still unknown.
Fig. 3.

Effects of the oral administration of 0.225 g/kg BW of dextran sulphate sodium (DSS) on the changes in the egg-yolk weight in hens administered DSS (DSS group) or water (CON group). Open bars represent the control group, and orange filled bars represent the DSS group. Values are the mean±SEM (CON and DSS, n=8 and 7). Asterisks (**) indicate significant differences be tween the CON and DSS groups (P<0.01). Lower case let ters indicate significant differences between the time points (P<0.05). (Nii ).

Effects of the oral administration of 0.225 g/kg BW of dextran sulphate sodium (DSS) on the changes in the egg-yolk weight in hens administered DSS (DSS group) or water (CON group). Open bars represent the control group, and orange filled bars represent the DSS group. Values are the mean±SEM (CON and DSS, n=8 and 7). Asterisks (**) indicate significant differences be tween the CON and DSS groups (P<0.01). Lower case let ters indicate significant differences between the time points (P<0.05). (Nii ). Disruption of the intestinal environment causes histological damage and shortening of villi, which absorb nutrients (Nii , b). Therefore, disruption of the intestinal environment is suspected to decrease the function of nutrient absorption in chickens and may affect poultry productivity, including the size of the yolk. Restricting feed ing to 55%–80% of the general feed intake for 5 d decreased whole egg weight on day 5 (Nii ). However, an increase in the energy concentration of the diet does not affect the weight of egg yolk (Pérez-Bonilla ). Thus, decreased nutrient absorption caused by a disrupted intestinal environment may contribute to the decreased egg yolk size, but a change in energy intake does not always seem to affect the egg yolk weight. Elkin reviewed the characteristics of the “restricted ovulatory” (R/O) chicken strain, which shows smaller ovarian follicles and higher circulating cholesterol (CHO) and triglycerides (TG) compared with wild-type chickens. Ho reported that high concentrations of cholesterol in R/O hens was not caused by overproduction of cholesterol, but was mainly caused by the failure to remove cholesterol from blood circulation by incorporating it into egg yolks. In addition, the R/O hens lack a 95-kDa membrane protein known as LR8, which is a lipoprotein receptor for uptake of VLDLy, an egg yolk precursor, into oocytes (Nimpf ). Thus, the lack of LR8 in ovarian follicles may be a primary factor underlying disrupted follicular growth and increased CHO and TG concentrations in the plasma. In our previous study, plasma TG and total CHO were greatly increased in both high and low concentrations of orally administered DSS hens, which showed lower egg productivity (Nii , b). However, the gene expression of LR8 in granulosa cells of F1 follicles was higher in the DSS group than in the control group (Nii ). The reason for this contradictory result is unknown, but the increase in LR8 gene expression may be caused by feedback from slow-growing follicles. Therefore, a slight disruption of the intestinal environment may decrease egg production and egg yolk size by disrupting VLDLy receptors such as LR8. Endocrine changes, such as changes in stress or gonadal hormones caused by disruption of the intestinal environment, may also lead to a decrease in egg yolk size. It has been reported that DSS-mediated intestinal inflammation increases plasma corticosterone levels in mice (Hassan ). Corticosterone stimulation by implantation of corticosterone pellets decreased plasma estrogen levels in White Leghorn hens (Henriksen ). However, R/O hens exhibited higher circulating FSH levels caused by a lack of negative feedback inhibition from lower inhibin secretion (Ocón-Grove, ). In addition, slight disruption of the intestinal environment caused by DSS stimulation increased the mRNA expression of FSH in the pituitary gland of laying hens (Nii ). Therefore, disordered endocrine hormone production caused by the disrupted intestinal environment may cause the decreased egg yolk size. Taken together, DSS is a useful chemical that causes severe or mild artificial intestinal inflammation in laying hens. Severe intestinal inflammation causes disruption of liver function and ovarian growth function by circulating endo-toxins from intestinal bacteria, resulting in the cessation of egg production. In contrast, slight disruption of the intestinal environment may cause dysfunction of egg yolk precursor uptake into ovarian follicles, but not suppression of liver function. Thus, disorders of the intestinal environment, including inflammation, may first lead to the cessation or delay of ovarian growth, the yolk precursor remaining in the blood, and finally, downregulation of yolk precursor production in the liver by negative feedback. However, the factors that disrupt ovarian growth are still unknown.

4. Improvement of mucosal immune function by probiotics

Disruption of the intestinal environment causes intestinal inflammation through disordered intestinal mucosal barrier function, resulting in decreased in egg production in chickens. Thus, maintaining optimal conditions in the intestinal environment and enhancing the mucosal barrier function are likely important for egg production. Probiotics are live bacteria that exert health benefits in host animals, and they have been well studied for their potential to improve poultry health and production. Treatment with Lactobacillus salivarius and L. reuteri, two lactic acid bacteria, increases the ratio of villus heights/crypt depth (V/C), which is an indicator of intestinal health in the duodenum of broiler chickens (Awad ). Bacillus and Entero-coccus also increase the V/C ratio in the small intestine of chicks (Li ; Huang ). Our previous study showed that oral administration of 1×108 cfu of L. reuteri increased villus height in the ileum of broiler chicks (Nii , d). Therefore, probiotics are expected to improve intestinal health by increasing the V/C ratio. Tight junctions, paracellular structures formed by several molecules, such as claudins, junctional adhesion molecules (JAMs), and zonula occludens (ZOs), are respon sible for the physical barrier function of the epithelium against pathogen invasion into mucosal tissue (Awad ). Treatment with L. plantarum decreases gut permeability by enhancing the expression levels of ZO1 and Claudin5 in the intestine of Salmonella-infected chickens (Wang ). In our study, L. reuteri treatment increased the gene expression of JAM2 in the digestive tract of broiler chicks (Nii ). L. reuteri also increased the expressions of Claudin1, Claudin5, JAM2, and ZO2, and decreased cecal permeability in the cecum of Salmonella Typhimurium heat-killed bacteria stimulated broiler chicks (Nii ). In addition, L. reuteri and C. butyricum treatment enhanced the expression of TLRs, AvBDs, and pro- and anti-inflammatory cytokine genes (Terada ). These results suggest that pro-biotics enhance intestinal mucosal barrier function by improving tight junctions and innate immune function in the intestine. Davis and Anderson (2002) reported that probiotic mixtures, including those containing L. acidophilus, L. casei, E. faecium, and Bifidobacterium thermophilum, improve micro-flora and egg production in laying hens. Bacillus licheniformis powder (2×1010 cfu/g) increased villus height in the jejunum of White Leghorn hens and improved egg quality, including shell thickness (Lei ). It has been reported that the Bacillus family plays a role in improving the microbiome and morphology of the intestine following egg production (Popov ). However, DSS-induced disruption of the intestinal environment resulted in a decrease in the V/C ratio and tight junction-related gene expression in the lower parts of the intestine, which was associated with decreased egg production (Nii ). These results suggest that decreased mucosal barrier function is probably related to egg production in laying hens. Thus, probiotics are expected to ameliorate egg production in laying hens by improving the intestinal environment, including mucosal barrier function. The mechanism of how probiotics affect egg production in laying hens are not well understood. We believe our DSS experimental model providing stress in the intestine is useful for studies to determine the mechanisms of how probiotics affect egg production in laying hens. Recently, it has been reported that the same genera of microbiota, including Lactobacillus, exists in both the cloaca and oviduct, and it has been suggested that some probiotic bacteria can translocate from the intestine to the oviduct (Lee ; Shterzer ). In humans, intravaginal administration as suppositories or topical application as a probiotic gel improves the mucosal immune response of the reproductive organ (Bustamante ). Therefore, probiotics should enhance the mucosal barrier function of the oviductal mucosa, similar to the effects of probiotics in the intestines of chickens. Further research is needed to determine the effects of probiotics on the mucosal barrier function of the oviduct of chickens.

5. Conclusion

Pathogenic infections in both the intestine and oviduct lead to dysfunction of egg production in laying hens through inflammation caused by mucosal immune reactions (Fig. 4). Intestinal inflammation causes an influx of LPS to the liver, disrupting liver function following disordered follicular growth in the ovary (Fig. 4a). Intestinal inflammation may directly disrupt follicular growth through LPS translocation. Oviductal inflammation causes an increase in proinflammatory cytokine production, leading to disrupted eggshell formation through decreased CaBP-D28K protein density (Fig. 4b). However, probiotic treatment may prevent pathogenic infection by enhancing the mucosal barrier function of the intestine, leading to improvement of liver function and ovarian follicular growth (Fig. 4c). Estrogen and proper antigens, such as probiotic stimulation, may also prevent infections by ameliorating the mucosal barrier function of the oviduct, leading to improved eggshell formation (Fig. 4d). Enhancing mucosal barrier function in the intestine and oviduct should improve egg production in laying hens. However, the mechanism underlying the decrease in egg yolk size caused by the disruption of the intestinal environment is still unknown. Further studies are necessary to address this problem.
Fig. 4.

Representative diagram describing the effects of inflammation condition and enhancement of mucosal barrier function in the intestine and oviduct on egg production of laying hens. (a) Intestinal inflammation caused by pathogen infection leads disruption of liver function through influx of lipopolysaccharide (LPS), and disorder of follicular growth. LPS probably directly disrupts the function of follicular growth in the ovary. (b) Inflammation in oviduct causes disorder of egg-shell formation. These inflammation in both intestine and oviduct leads disorder of egg production. (c) Probiotics enhances mucosal barrier function in the intestine, it may be following prevention of liver and ovarian functional disorder caused by disruption of intestinal mucosal barrier function. (d) Estrogen and proper antigen stimulation such as probiotics stimulation enhance mucosal barrier function in the oviduct. The enhancement of barrier function in both intestine and ovary may contribute to improvement of egg production.

Representative diagram describing the effects of inflammation condition and enhancement of mucosal barrier function in the intestine and oviduct on egg production of laying hens. (a) Intestinal inflammation caused by pathogen infection leads disruption of liver function through influx of lipopolysaccharide (LPS), and disorder of follicular growth. LPS probably directly disrupts the function of follicular growth in the ovary. (b) Inflammation in oviduct causes disorder of egg-shell formation. These inflammation in both intestine and oviduct leads disorder of egg production. (c) Probiotics enhances mucosal barrier function in the intestine, it may be following prevention of liver and ovarian functional disorder caused by disruption of intestinal mucosal barrier function. (d) Estrogen and proper antigen stimulation such as probiotics stimulation enhance mucosal barrier function in the oviduct. The enhancement of barrier function in both intestine and ovary may contribute to improvement of egg production. In addition, the DSS experimental model introduced in this review is expected to be a new method for studies on the mechanisms of the relationship between the intestinal environment and poultry production, as well as to examine the effects of feed additives in laying hens. The findings introduced in this review will contribute to the understanding of the mucosal barrier function of the intestine and oviduct, and improve poultry egg production in laying hens.
  59 in total

1.  Induction of eggshell apex abnormalities in broiler breeder hens.

Authors:  A Feberwee; W J M Landman
Journal:  Avian Pathol       Date:  2010-04       Impact factor: 3.378

2.  Localisation of MHC class II, lymphocytes and immunoglobulins in the oviduct of laying and moulting hens.

Authors:  Y Yoshimura; T Okamoto; T Tamura
Journal:  Br Poult Sci       Date:  1997-12       Impact factor: 2.095

Review 3.  An update on alternatives to antimicrobial growth promoters for broilers.

Authors:  Gerard Huyghebaert; Richard Ducatelle; Filip Van Immerseel
Journal:  Vet J       Date:  2010-04-09       Impact factor: 2.688

4.  Histological parameters to evaluate intestinal health on broilers challenged with Eimeria and Clostridium perfringens with or without enramycin as growth promoter.

Authors:  B L Belote; A Tujimoto-Silva; P H Hümmelgen; A W D Sanches; J C S Wammes; R M Hayashi; E Santin
Journal:  Poult Sci       Date:  2018-07-01       Impact factor: 3.352

5.  The effect of estrogen on the early cytotoxic response to IB virus infection in hen oviduct.

Authors:  Takahiro Nii; Naoki Isobe; Yukinori Yoshimura
Journal:  Vet Immunol Immunopathol       Date:  2015-01-05       Impact factor: 2.046

6.  Tissue distribution of haemolytic Gallibacterium anatis isolates in laying birds with reproductive disorders.

Authors:  C Neubauer; M De Souza-Pilz; A M Bojesen; M Bisgaard; M Hess
Journal:  Avian Pathol       Date:  2009-02       Impact factor: 3.378

7.  The effects of feeding the direct-fed microbial, primalac, on growth parameters and egg production in single comb white leghorn hens.

Authors:  G S Davis; K E Anderson
Journal:  Poult Sci       Date:  2002-06       Impact factor: 3.352

Review 8.  Review of induced molting by feed removal and contamination of eggs with Salmonella enterica serovar Enteritidis.

Authors:  Neal J Golden; Harry H Marks; Margaret E Coleman; Carl M Schroeder; Nathan E Bauer; Wayne D Schlosser
Journal:  Vet Microbiol       Date:  2008-03-25       Impact factor: 3.293

9.  Characterization of microbial communities in the chicken oviduct and the origin of chicken embryo gut microbiota.

Authors:  Sangwon Lee; Tae-Min La; Hong-Jae Lee; In-Soo Choi; Chang-Seon Song; Seung-Yong Park; Joong-Bok Lee; Sang-Won Lee
Journal:  Sci Rep       Date:  2019-05-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.